Atomistry » Zinc » PDB 2w22-2wfr » 2weg
Atomistry »
  Zinc »
    PDB 2w22-2wfr »
      2weg »

Zinc in PDB 2weg: Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

Enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

All present enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors:
4.2.1.1;

Protein crystallography data

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weg was solved by A.D.Scott, C.Phillips, A.Alex, A.Bent, R.O'brien, L.Damian, L.H.Jones, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 26.64 / 1.10
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 42.432, 41.223, 72.038, 90.00, 104.26, 90.00
R / Rfree (%) 16.5 / 18.3

Other elements in 2weg:

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors also contains other interesting chemical elements:

Fluorine (F) 1 atom

Zinc Binding Sites:

The binding sites of Zinc atom in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors (pdb code 2weg). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weg:

Zinc binding site 1 out of 1 in 2weg

Go back to Zinc Binding Sites List in 2weg
Zinc binding site 1 out of 1 in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1262

b:4.5
occ:1.00
 N2 A:FBV1263 1.9 5.1 1.0
NE2 A:HIS94 2.0 4.0 1.0
ND1 A:HIS119 2.0 3.4 1.0
NE2 A:HIS96 2.1 4.6 1.0
CE1 A:HIS119 2.9 4.7 1.0
CE1 A:HIS94 3.0 5.1 1.0
CD2 A:HIS96 3.0 4.4 1.0
O2 A:FBV1263 3.0 5.2 1.0
CD2 A:HIS94 3.0 4.5 1.0
S A:FBV1263 3.0 4.9 1.0
CE1 A:HIS96 3.1 4.6 1.0
CG A:HIS119 3.1 4.1 1.0
CB A:HIS119 3.6 5.1 1.0
OG1 A:THR199 3.9 5.0 1.0
OE1 A:GLU106 4.0 5.8 1.0
ND1 A:HIS94 4.1 4.6 1.0
O1 A:FBV1263 4.1 5.3 1.0
C4 A:FBV1263 4.1 7.3 1.0
NE2 A:HIS119 4.1 4.8 1.0
CG A:HIS94 4.2 4.4 1.0
ND1 A:HIS96 4.2 5.3 1.0
CG A:HIS96 4.2 5.1 1.0
CD2 A:HIS119 4.2 4.7 1.0
C1 A:GOL1264 4.4 7.5 1.0
F A:FBV1263 4.8 7.0 1.0
C5 A:FBV1263 4.9 7.4 1.0
C3 A:FBV1263 4.9 7.7 1.0
CD A:GLU106 4.9 6.2 1.0
C2 A:GOL1264 5.0 7.3 1.0

Reference:

A.D.Scott, C.Phillips, A.Alex, M.Flocco, A.Bent, A.Randall, R.O'brien, L.Damian, L.H.Jones. Thermodynamic Optimisation in Drug Discovery: A Case Study Using Carbonic Anhydrase Inhibitors. Chemmedchem V. 4 1985 2009.
ISSN: ISSN 1860-7179
PubMed: 19882701
DOI: 10.1002/CMDC.200900386
Page generated: Thu Oct 17 04:52:57 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy